| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.56B | +22.1% |
| Cost of Revenue | $3.04B | +28.0% |
| Gross Profit | $1.52B | +11.9% |
| R&D Expense | $159.8M | +53.2% |
| SG&A Expense | $194.9M | +35.1% |
| Operating Income | $566.3M | -21.5% |
| Interest Expense | $54.8M | +66.4% |
| Pre-tax Income | $508.5M | -26.5% |
| Income Tax | $99.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $132.7M | -9.9% |
| Accounts Receivable | $522.5M | -4.4% |
| Inventory | $1.41B | +29.0% |
| Current Assets | $2.18B | +18.1% |
| Total Assets | $5.17B | +6.0% |
| Current Liabilities | $992.0M | -14.2% |
| Long-term Debt | $1.37B | +55.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $58.5M | -85.8% |
| Capital Expenditures | $86.2M | -21.6% |
| Investing Cash Flow | -$134.2M | +83.6% |
| Financing Cash Flow | $64.0M | +162.2% |
| Free Cash Flow | -$27.7M | -109.2% |
| -26.2% |
| Net Income | $399.5M | -27.4% |
| EPS (Basic) | $5.55 | -34.8% |
| EPS (Diluted) | $5.42 | -34.7% |
| Total Liabilities |
| $2.80B |
| +7.4% |
| Stockholders' Equity | $2.26B | +2.0% |